Vincristine Sulfate Injection (Vincristine Sulfate) Patient Information: Side Effects and Drug Images at RxList

Pill Identifier Search

May 27, 2012

Vincristine Sulfate Injection

Multiple Myeloma »

What is multiple myeloma?

Multiple myeloma is a type of cancer. Cancer is a group of many related diseases. Myeloma is a cancer that starts in plasma cells, a type of white blood cell. It's the most common type of plasma cell cancer.

Normal blood cells

Most blood cells develop from cells in the bone marrow called stem cells. Bone marrow is the soft material in the center of most bones.

Stem cells mature into different types of blood cells. Each type has a special job:

White blood cells help fight infection. There are several types of white blood cells.
Red blood cells carry oxygen to tissues throughout the body.
Platelets help form blood clots that control bleeding.

Plasma cells are white blood cells that make antibodies. Antibodies are part of the immune system. They work with other parts of the immune system to help protect the body from germs and other ...

Read the Multiple Myeloma article »

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Vincristine Sulfate Injection User Reviews >>

Vincristine Sulfate Injection

font size

Vincristine Sulfate Injection, USP (vincristine sulfate)

PRESERVATIVE FREE SOLUTION

WARNINGS

Caution-This preparation should be administered by individuals experienced in the administration of Vincristine Sulfate Injection, USP (vincristine sulfate) . It is extremely important that the intravenous needle or catheter be properly positioned before any vincristine is injected. Leakage into surrounding tissue during intravenous administration of Vincristine Sulfate Injection, USP (vincristine sulfate) may cause considerable irritation. If extravasation occurs, the injection should be discontinued immediately, and any remaining portion of the dose should then be introduced into another vein. Local injection of hyaluronidase and the application of moderate heat to the area of leakage help disperse the drug and are thought to minimize discomfort and the possibility of cellulitis.

FATAL IF GIVEN INTRATHECALLY. FOR INTRAVENOUS USE ONLY.

See WARNINGS section for the treatment of patients given intrathecal Vincristine Sulfate Injection, USP (vincristine sulfate) .

DRUG DESCRIPTION

Vincristine Sulfate Injection, USP (vincristine sulfate) is the salt of an alkaloid obtained from a common flowering herb, the periwinkle plant (Vinca rosea Linn). Originally known as leurocristine, it has also been referred to as LCR and VCR. The molecular formula for Vincristine Sulfate, USP is C₄₆H₅₆N₄O₁₀•H₂SO₄. It has a molecular weight of 923.04.

The structural formula is as follows:

Vincristine Sulfate Structural Formula Illustration

Vincristine Sulfate, USP is a white to off-white powder. It is soluble in methanol, freely soluble in water, but only slightly soluble in 95% ethanol. In 98% ethanol, Vincristine Sulfate, USP has an ultraviolet spectrum with maxima at 221 nm (ε¸+47,100).

Vincristine Sulfate Injection, USP (vincristine sulfate) is a sterile, preservative-free, single use only solution available for intravenous use in 2 mL (1 mg and 2 mg) vials. Each mL contains 1 mg Vincristine Sulfate, USP, 100 mg mannitol and Water for Injection, USP q.s. Sulfuric acid or sodium hydroxide have been added for pH control. The pH of Vincristine Sulfate Injection, USP (vincristine sulfate) ranges from 4.0 to 5.0. At the time of manufacture, the air in the containers is replaced by nitrogen.

Last reviewed on RxList: 9/16/2008
This monograph has been modified to include the generic and brand name in many instances.